Integrated Cancer Center of the CHU de Québec

Québec G1J 1Z4

0 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumor, Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma

Studies at this site

• First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas — Completed